Influenza A virus subtype H1N1: all 21 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Cell Mediated Immunity Against RSV and Influenza in a Human Experimental ChallengeCompletedNCT02755948Not applicableResults posted
- Immunologic Response to Inactivated Vaccine for Novel H1N1 VirusCompletedNCT01023711Not applicableResults posted
- Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese ChildrenCompletedNCT01001169Phase 2Results posted
- Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and YouthCompletedNCT00992836Phase 2Results posted
- Novartis H1N1 Vaccine in Pregnant WomenCompletedNCT00992719Phase 2Results posted
- Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant WomenCompletedNCT00992017Phase 2Results posted
- H1N1 Vaccine in Pregnant WomenCompletedNCT00963430Phase 2Results posted
- Sanofi H1N1 + TIV - Adults and ElderlyCompletedNCT00943878Phase 2Results posted
- Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly PopulationsCompletedNCT00943631Phase 2Results posted
- CSL H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly PopulationsCompletedNCT00943488Phase 2Results posted
- Sanofi Pasteur, TIV + H1N1, Pediatric PopulationCompletedNCT00943202Phase 2Results posted
- Monocytic Expression of Heme Oxidase-1 (HO-1) in Sickle Cell Patients and Correlation With the Humoral Immune Response to Vaccine and With Allo-immunization.CompletedNCT03111589Not applicable
- Phase I/II Safety and Immunogenicity of Pandemic Live Attenuated Influenza Vaccine (PLAIV) Candidate Strain A/17/CA/2009/38 (H1N1) in Healthy ThaisCompletedNCT01666262Phase 1/2
- A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) VaccineCompletedNCT01201902Phase 3
- Effect of Age and Prior Immunity on Response to H1N1 Vaccines in ChildrenWithdrawnNCT01097941Phase 4
- Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid TumorsCompletedNCT01031719Phase 3
- Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk PatientsCompletedNCT01022905Phase 4
- Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)CompletedNCT01008813Phase 2
- Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Pediatric PopulationCompletedNCT01007201Not applicable
- Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Adults and EldersCompletedNCT01003145Not applicable
- Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1WithdrawnNCT00989274Phase 2